December 31, 2008
2008
- ReadSacchi V. Maraviroc (Celsentri) in HIV treatment. Farmeconomia e percorsi terapeutici 2008; 9(4): 219-222. Edited by AdRes Health Economics & Outcomes Research
- ReadSacchi V. Telbivudine (Sebivo) in patients with hepatitis B virus (HBV) chronic infection. Farmeconomia e percorsi terapeutici 2008; 9(4): 215-218. Edited by AdRes Health Economics & Outcomes Research
- ReadPradelli L. Usefulness and limitation of DDD and PDD analyses. 12 months of solid oral antipsychotics prescribing data for the NHS-reimbursed treatment of schizophrenia in Italy. Farmeconomia e percorsi terapeutici 2008; 9(4): 191-196
- ReadSacchi V. Daptomycin (Cubicin) in patients with complicated skin or soft-tissue infections. Farmeconomia e percorsi terapeutici 2008; 9(3): 163-166. Edited by AdRes Health Economics & Outcomes Research
- ReadSacchi V. Entecavir (Baraclude) in patients with chronic hepatitis B virus (HPV) infection. Farmeconomia e percorsi terapeutici 2008; 9(3): 157-161. Edited by AdRes Health Economics & Outcomes Research
- ReadIannazzo S, Pradelli L. Cost-efficacy analysis of hormonal treatments for advanced prostate cancer. Farmeconomia e percorsi terapeutici 2008; 9(3): 147-156
- ReadZaniolo O, Sacchi V, Pradelli L. Budget impact of vildagliptin. Farmeconomia e percorsi terapeutici 2008; 9(3): 137-146
- ReadIannazzo S, Pradelli L, Zaniolo O. Pharmacoeconomic analysis of valsartan for the treatment of chronic congestive heart failure in Italy. Farmeconomia e percorsi terapeutici 2008; 9(3): 125-135
- ReadSacchi V. Rotigotine patches (Neupro) in early Parkinson’s disease. Farmeconomia e percorsi terapeutici 2008; 9(2): 115-119. Edited by AdRes Health Economics & Outcomes Research
- ReadSacchi V. Natalizumab (Tysabri) in multiple sclerosis patients. Farmeconomia e percorsi terapeutici 2008; 9(2): 109-114. Edited by AdRes Health Economics & Outcomes Research
- ReadZaniolo O, Iannazzo S. Sartans: differences, similitudes and costs. Farmeconomia e percorsi terapeutici 2008; 9(2): 69-88
- ReadPradelli L. Parnaparin: review of the literature. Farmeconomia e percorsi terapeutici 2008; 9(1): 27-40
- ReadIannazzo S, Pradelli L. Solifenacin in overactive bladder syndrome: pharmacoeconomic analysis. Farmeconomia e percorsi terapeutici 2008; 9(1): 5-14
- ReadIannazzo S, Zaniolo O, Pradelli L. Economic evaluation of treatment with orlistat in Italian obese patients. Curr Med Res Opin 2008; 24(1): 63-74
- ReadPradelli L, Eandi M. Palonosetron in the prevention of chemotherapy-induced nausea and vomiting (CINV) in Italy: pharmacologic, clinical and economic aspects. Tumori 2008; 94: 26-32
- ReadCremonesi G, Pradelli L. Profilo farmacologico, clinico ed economico dell’associazione fissa di beclometasone dipropionato e formoterolo in formulazione extra-fine nella terapia di pazienti con asma bronchiale. Profili in Farmacoeconomia 2008; 7
- ReadZaniolo O, Pradelli L. La schizofrenia: percorsi diagnostico-terapeutici e costo di malattia. Profili in Farmacoeconomia 2008; 6
No Comments
Sorry, the comment form is closed at this time.